MEXICO CITY, March 5, 2021 /PRNewswire/ -- Grupo Aeromexico S.A.B. de C.V. ("Aeromexico") (BMV: AEROMEX) today reported February 2021 operational results.
Grupo Aeromexico transported 898 thousand passengers in February 2021, a 39.7% year-on-year decrease. Passengers carried were at 60.3% of February 2020 levels - domestic at 75.1% and international at 30.9%.
Aeromexico's capacity, measured in Available Seat Kilometers (ASKs) decreased by 46.4% year-on-year, which represented 53.6% of its February 2020 capacity.
Demand measured in Revenue Passenger Kilometers (RPKs) decreased by 57.9% year-on-year, which represented 42.1% of its February 2020 demand.
Aeromexico's February load factor was 66.1%, an increase of 0.7 p.p. versus January 2021 and a 14.0 p.p. decrease versus February 2020. Domestic load factor was 82.3%, an increase of 3.1 p.p. compared to February 2020.
February
YTD February
2021
2020
Var
2021
2020
Var
RPKs (itinerary + charter, millions)
Domestic
731
862
-15.2%
1,582
1,791
-11.7%
International
561
2,203
-74.6%
1,451
4,834
-70.0%
Total
1,292
3,065
-57.9%
3,033
6,625
-54.2%
ASKs (itinerary + charter, millions)
Domestic
888
1,088
-18.4%
2,042
2,354
-13.3%
International
1,164
2,740
-57.5%
2,756
5,909
-53.4%
Total
2,052
3,829
-46.4%
4,798
8,263
-41.9%
Load Factor (itinerary, %)
p.p.
p.p.
Domestic
82.3
79.3
3.1
77.5
76.1
1.4
International
52.6
80.4
-27.8
56.3
81.8
-25.5
Total
66.1
80.1
-14.0
65.7
80.2
-14.5
Passengers (itinerary + charter, thousands)
Domestic
743
989
-24.9%
1,597
2,026
-21.2%
International
154
501
-69.1%
394
1,113
-64.6%
Total
898
1,490
-39.7%
1,990
3,140
-36.6%
Figures may not sum to total due to rounding. The information included within this report has not been audited and does not provide information on the Company's future performance. Aeromexico's future performance depends on many factors and it cannot be inferred that any period's performance or its year-over-year comparison will be an indicator of similar future performance.
Glossary:
"RPKs" Revenue Passenger Kilometers represent one revenue-passenger transported one kilometer. This includes itinerary and charter flights. The total RPKs equals the number of revenue-passengers transported multiplied by the total distance flown.
"ASKs" Available Seat Kilometers represent the number of available seats multiplied by the distance flown. This metric is an indicator of the airline's capacity. It equals one seat offered for one kilometer, whether the seat is used.
"Load Factor" equals the number of passengers transported as a percentage of the number of seats offered. It is a measure of the airline's capacity utilization. This metric considers the total passengers transported and total seats available in itinerary flights only.
"Passengers" refers to the total number of passengers transported by the airline.
Grupo Aeroméxico confirms that its voluntary process of financial restructuring under Chapter 11 of the legislation of the United States of America, will be carried out in an orderly manner while it continues operating and offering services to its customers with the same quality that characterizes it, contracting from its suppliers the goods and services required for its operation. The Company will use the advantages of Chapter 11 to strengthen its financial position and liquidity, protect and preserve its operations and assets, and implement the necessary adjustments to face the impact of COVID-19.
This press release contains certain forward-looking statements that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as "believe," "anticipate," "plan," "expect,", "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "should" and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Grupo Aeromexico
Grupo Aeromexico, S.A.B. de C.V. is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and the promotion of passenger loyalty programs. Aeroméxico, Mexico's global airline, has its main operations center in Terminal 2 of the Mexico City International Airport. Its destination network has reach in Mexico, the United States, Canada, Central America, South America, Asia and Europe. The Group's current operating fleet includes Boeing 787 and 737 aircraft, as well as the latest generation Embraer 190. Aeroméxico is a founding partner of SkyTeam, an alliance that celebrates 20 years and offers connectivity in more than 170 countries, through the 19 partner airlines. Aeroméxico created and implemented a Health and Hygiene Management System (SGSH) to protect its clients and collaborators at all stages of its operation. www.aeromexico.com www.skyteam.co
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...